RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
H Lundbeck A/S Stock

H Lundbeck A/S ROCE 2024

H Lundbeck A/S ROCE

0.12

Ticker

LUN.CO

ISIN

DK0010287234

WKN

922351

In 2024, H Lundbeck A/S's return on capital employed (ROCE) was 0.12, a 0% increase from the 0 ROCE in the previous year.

H Lundbeck A/S Aktienanalyse

What does H Lundbeck A/S do?

H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling H Lundbeck A/S's Return on Capital Employed (ROCE)

H Lundbeck A/S's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing H Lundbeck A/S's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

H Lundbeck A/S's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in H Lundbeck A/S’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about H Lundbeck A/S stock

What is the ROCE (Return on Capital Employed) of H Lundbeck A/S this year?

The ROCE of H Lundbeck A/S is 0.12 undefined this year.

How has the ROCE (Return on Capital Employed) of H Lundbeck A/S developed compared to the previous year?

The ROCE of H Lundbeck A/S has increased by 0% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of H Lundbeck A/S?

A high Return on Capital Employed (ROCE) indicates that H Lundbeck A/S has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of H Lundbeck A/S?

A low ROCE (Return on Capital Employed) can indicate that H Lundbeck A/S has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from H Lundbeck A/S impact the company?

An increase in the ROCE of H Lundbeck A/S can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of H Lundbeck A/S affect the company?

A decrease in ROCE of H Lundbeck A/S can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of H Lundbeck A/S?

Some factors that can affect H Lundbeck A/S's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of H Lundbeck A/S so important for investors?

The ROCE of H Lundbeck A/S is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can H Lundbeck A/S take to improve the ROCE?

To improve the ROCE, H Lundbeck A/S can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does H Lundbeck A/S pay?

Over the past 12 months, H Lundbeck A/S paid a dividend of 2.5 DKK . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, H Lundbeck A/S is expected to pay a dividend of 15.45 DKK.

What is the dividend yield of H Lundbeck A/S?

The current dividend yield of H Lundbeck A/S is 1.45 %.

When does H Lundbeck A/S pay dividends?

H Lundbeck A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of H Lundbeck A/S?

H Lundbeck A/S paid dividends every year for the past 10 years.

What is the dividend of H Lundbeck A/S?

For the upcoming 12 months, dividends amounting to 15.45 DKK are expected. This corresponds to a dividend yield of 8.94 %.

In which sector is H Lundbeck A/S located?

H Lundbeck A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von H Lundbeck A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of H Lundbeck A/S from 3/28/2022 amounting to 2 DKK, you needed to have the stock in your portfolio before the ex-date on 3/24/2022.

When did H Lundbeck A/S pay the last dividend?

The last dividend was paid out on 3/28/2022.

What was the dividend of H Lundbeck A/S in the year 2023?

In the year 2023, H Lundbeck A/S distributed 2 DKK as dividends.

In which currency does H Lundbeck A/S pay out the dividend?

The dividends of H Lundbeck A/S are distributed in DKK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The H Lundbeck A/S stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von H Lundbeck A/S

Our stock analysis for H Lundbeck A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of H Lundbeck A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.